Dr. Cameron Clokie became a DDS (Doctor of Dental Surgery) in 1985 after which he continued comprehensive medical studies graduating in 1990. Two years later, he was appointed as Head of Oral and Maxillofacial surgery and received a PH.D in bone regeneration from McGill University in Quebec, Canada. A year later, in 1993, after becoming a Fellow of the Royal College of Dentists of Canada and a Diplomat of the American Board of Oral and Maxillofacial Surgery, he opened his bone research group at McGill University, which was later moved to the University of Toronto.
As a dedicated medic, his life’s work has been in the development of bio-implants that will eventually replace autogenous bone grafts. A protein known as BMP (Bone Morphogenetic Protein), discovered by renowned orthopedic surgeon, Marshall Urist, in the 1950s, under whom Dr. Clokie worked for 4 years, is implanted into the affected area, tricking adult stem cells into triggering new bone tissue growth.
The theory of stem cell therapy is not new and the many breakthroughs into the research of regenerative tissue have been highlighted in medical and scientific journals, but it was not until several years ago that Dr. Clokie began providing an alternative in reconstructive dental and facial surgery.
Widely sought after for his highly informative publications and presentations, he has lectured nationally and internationally on a wide variety of topics including “how maintaining regular dental care affects overall health” and regenerative medicine.
Involved in teaching and sharing his innovative discoveries with the medical profession, the entrepreneurial side of his character has resulted in him becoming the holder of 25 U.S. and International current or pending experimental patents including many related to bone healing.
He recently retired from academia and is now the CEO of Induce Inc., a company in the forefront of the development and improvement of BPM striving to reduce side effects and costs, which Medicare and other insurances do not cover.